RU2013155903A - Композиции, способы и устройства для респираторной доставки двух или более активных средств - Google Patents
Композиции, способы и устройства для респираторной доставки двух или более активных средств Download PDFInfo
- Publication number
- RU2013155903A RU2013155903A RU2013155903/15A RU2013155903A RU2013155903A RU 2013155903 A RU2013155903 A RU 2013155903A RU 2013155903/15 A RU2013155903/15 A RU 2013155903/15A RU 2013155903 A RU2013155903 A RU 2013155903A RU 2013155903 A RU2013155903 A RU 2013155903A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- respirable
- glycopyrrolate
- formoterol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
- A61L9/02—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/036868 WO2012158166A1 (fr) | 2011-05-17 | 2011-05-17 | Compositions, procédés et systèmes d'administration par voie respiratoire d'au moins deux agents actifs |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2013155903A true RU2013155903A (ru) | 2015-06-27 |
Family
ID=47177229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013155903/15A RU2013155903A (ru) | 2011-05-17 | 2011-05-17 | Композиции, способы и устройства для респираторной доставки двух или более активных средств |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2709447A4 (fr) |
JP (1) | JP2014518871A (fr) |
KR (1) | KR20140032404A (fr) |
CN (1) | CN103687483A (fr) |
AU (1) | AU2011368334A1 (fr) |
BR (1) | BR112013029507A2 (fr) |
CA (1) | CA2835927A1 (fr) |
EA (1) | EA201490991A1 (fr) |
IL (1) | IL229260A0 (fr) |
MX (1) | MX2013013440A (fr) |
RU (1) | RU2013155903A (fr) |
SG (1) | SG194896A1 (fr) |
WO (1) | WO2012158166A1 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3111926T3 (pl) | 2009-05-29 | 2020-06-29 | Pearl Therapeutics, Inc. | Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
WO2014118532A1 (fr) | 2013-01-31 | 2014-08-07 | Prosonix Limited | Compositions pharmaceutiques contenant des particules cristallines multi-composant appropriées pour être utilisées dans un traitement par inhalation |
US20140275517A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
MX2015016058A (es) * | 2013-05-22 | 2016-12-20 | Pearl Therapeutics Inc | Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos. |
PT3096737T (pt) * | 2013-12-30 | 2018-04-27 | Chiesi Farm Spa | Composição de solução de aerossol pressurizado estável de brometo de glicopirrónio e formoterol |
SG11201605311UA (en) | 2013-12-30 | 2016-07-28 | Chiesi Farma Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
JP6502501B2 (ja) | 2014-09-09 | 2019-04-17 | ベクトゥラ・リミテッド | グリコピロレートを含む製剤、方法、及び装置 |
US20160310410A1 (en) | 2015-04-24 | 2016-10-27 | Glenmark Specialty S.A. | Pharmaceutical compositions comprising arformoterol and glycopyrronium |
EP3288541B1 (fr) * | 2015-05-01 | 2020-09-02 | Board of Regents, The University of Texas System | Compositions matricielles fragiles à médicaments multiples |
CN105125542A (zh) * | 2015-08-23 | 2015-12-09 | 杭州紫金医药科技有限公司 | 含噻托溴铵和福莫特罗的药物组合物及其用途和制剂 |
CN106880636A (zh) * | 2015-12-15 | 2017-06-23 | 天津金耀集团有限公司 | 一种环索奈德单方和复方干粉吸入剂组合物 |
CN106880637B (zh) * | 2015-12-15 | 2021-01-29 | 天津金耀集团有限公司 | 一种环索奈德福莫特罗噻托溴铵复方干粉吸入剂组合物 |
CN106943350A (zh) * | 2017-03-14 | 2017-07-14 | 上海现代药物制剂工程研究中心有限公司 | 含毒蕈碱受体拮抗剂和β2受体激动剂的气雾剂及制备方法 |
EP3880169A1 (fr) * | 2018-11-12 | 2021-09-22 | Kindeva Drug Delivery L.P. | Formulation d'uméclidinium et de vilantérol et inhalateur |
WO2021071967A1 (fr) * | 2019-10-09 | 2021-04-15 | Island Breeze Systems Ca, Llc | Compositions permettant l'administration par voie pulmonaire de cannabinoïdes, méthodes et systèmes associés |
CN111467498A (zh) * | 2020-05-14 | 2020-07-31 | 王兆霖 | 药物组合物制剂 |
CN116710104A (zh) * | 2021-01-08 | 2023-09-05 | 江苏恒瑞医药股份有限公司 | 可通过定量吸入器递送的药物组合物 |
WO2023283441A1 (fr) * | 2021-07-09 | 2023-01-12 | Astrazeneca Pharmaceuticals Lp | Compositions, méthodes et systèmes pour l'administration d'un médicament en aérosol |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060165606A1 (en) * | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
DE69814428T2 (de) * | 1997-09-29 | 2004-05-13 | Nektar Therapeutics, San Carlos | In verneblern verwendbare, stabilisierte zubereitungen |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
SE527190C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid |
EP1718336B1 (fr) * | 2004-02-06 | 2008-06-25 | MEDA Pharma GmbH & Co. KG | Nouvelle combinaison d'anticholinergique et de beta-mimetiques pour le traitement de maladies respiratoires |
US8815258B2 (en) * | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
PL3111926T3 (pl) * | 2009-05-29 | 2020-06-29 | Pearl Therapeutics, Inc. | Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego |
-
2011
- 2011-05-17 KR KR1020137030446A patent/KR20140032404A/ko not_active Application Discontinuation
- 2011-05-17 CA CA2835927A patent/CA2835927A1/fr not_active Abandoned
- 2011-05-17 WO PCT/US2011/036868 patent/WO2012158166A1/fr active Application Filing
- 2011-05-17 SG SG2013083431A patent/SG194896A1/en unknown
- 2011-05-17 JP JP2014511329A patent/JP2014518871A/ja active Pending
- 2011-05-17 EP EP11865780.8A patent/EP2709447A4/fr not_active Withdrawn
- 2011-05-17 MX MX2013013440A patent/MX2013013440A/es unknown
- 2011-05-17 BR BR112013029507A patent/BR112013029507A2/pt not_active IP Right Cessation
- 2011-05-17 CN CN201180072341.4A patent/CN103687483A/zh active Pending
- 2011-05-17 EA EA201490991A patent/EA201490991A1/ru unknown
- 2011-05-17 RU RU2013155903/15A patent/RU2013155903A/ru not_active Application Discontinuation
- 2011-05-17 AU AU2011368334A patent/AU2011368334A1/en not_active Abandoned
-
2013
- 2013-11-05 IL IL229260A patent/IL229260A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL229260A0 (en) | 2014-01-30 |
EA201490991A1 (ru) | 2014-09-30 |
MX2013013440A (es) | 2014-06-05 |
SG194896A1 (en) | 2013-12-30 |
CA2835927A1 (fr) | 2012-11-22 |
EP2709447A4 (fr) | 2014-10-22 |
JP2014518871A (ja) | 2014-08-07 |
KR20140032404A (ko) | 2014-03-14 |
EP2709447A1 (fr) | 2014-03-26 |
BR112013029507A2 (pt) | 2019-09-24 |
CN103687483A (zh) | 2014-03-26 |
WO2012158166A1 (fr) | 2012-11-22 |
AU2011368334A1 (en) | 2013-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013155903A (ru) | Композиции, способы и устройства для респираторной доставки двух или более активных средств | |
Anderson et al. | Inhaled medicines: past, present, and future | |
JP7169693B2 (ja) | 呼吸器疾患の治療 | |
CN100398094C (zh) | 福莫特罗超细制剂 | |
RU2015154720A (ru) | Композиции, способы и системы для респираторной доставки трех или более активных средств | |
RU2005108050A (ru) | Фармацевтические продукты и композиции, содержащие специфические антихолинергические средства, агонисты бета-2 и кортикостероиды | |
US20170027908A1 (en) | Pharmaceutical Composition | |
JP5809985B2 (ja) | 4−{(1r)−2−[(6−{2−[(2,6−ジクロロベンジル)オキシ]エトキシ}ヘキシル)アミノ]−1−ヒドロキシエチル}−2−(ヒドロキシメチル)フェノールを含む医薬製剤 | |
AU2006275137A1 (en) | Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation | |
SK16372001A3 (sk) | Farmaceutický prostriedok, spôsob jeho výroby a jeho použitie | |
JP6129081B2 (ja) | 頻拍を治療するためのグリコピロラートの使用 | |
JP2013512270A (ja) | ムスカリン受容体拮抗薬およびβ2アドレナリン受容体作動薬の組み合わせ | |
US20070276048A1 (en) | Unit dose formulations comprising an inhalable solution of albuterol | |
CN101657191B (zh) | 包括福莫特罗和二丙酸倍氯米松的组合物在制备用于预防和/或治疗哮喘恶化的药物中的用途 | |
UA119774C2 (uk) | Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл) | |
CN103476412B (zh) | 用于改善呼吸系统疾病患者睡眠质量的阿地铵 | |
US20170367971A1 (en) | Novel propellant containing preparations for tiotropium | |
TW201735914A (zh) | 用於治療慢性阻塞性肺疾病之醫藥組成物 | |
US20090163531A1 (en) | Use of Tiotropium Salts in the Treatment of Severe Persistent Asthma | |
ES2882978T3 (es) | Uso de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-metilbenzamida en la prevención de exacerbaciones agudas de la enfermedad de obstrucción pulmonar crónica | |
US20170119744A1 (en) | Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent | |
JP7280627B2 (ja) | 慢性閉塞性肺疾患の急性増悪の処置における3-[5-アミノ-4-(3-シアノベンゾイル)-ピラゾール-1-イル]-n-シクロプロピル-4-メチルベンズアミドの使用 | |
Armstrong et al. | The role of aclidinium bromide in the treatment of chronic obstructive pulmonary disease | |
WO2023192445A1 (fr) | Formulations liquides d'indacatérol et de glycopyrronium | |
Chaplin et al. | Long‐acting bronchodilators: their properties and place in treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20160627 |